Beam Therapeutics (BEAM) Other Working Capital Changes (2019 - 2026)

Beam Therapeutics (BEAM) has reported Other Working Capital Changes for 8 consecutive years, with -$6.4 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Other Working Capital Changes fell 7040.45% year-over-year to -$6.4 million; the TTM figure through Mar 2026 stood at -$19.8 million (down 222.53% YoY), while the FY2025 annual figure was -$13.5 million, down 4.28% from the prior year.
• Other Working Capital Changes fell to -$6.4 million in Q1 2026 per BEAM's latest filing, from $8.1 million in the prior quarter.
• Across five years, Other Working Capital Changes topped out at $31.9 million in Q1 2026 and bottomed at -$6.2 million in Q2 2024.
• Historically, Other Working Capital Changes has averaged $2.8 million across 5 years, with a median of -$49000.0 in 2025.
• Annual changes were most pronounced in 2022 — Other Working Capital Changes surged 138366.67% — and 2026, when it tumbled 7040.45%.
• Beam Therapeutics' Other Working Capital Changes stood at -$1.1 million in 2022, then surged by 4776.17% to $49.8 million in 2023, then plunged by 106.57% to -$3.3 million in 2024, then soared by 347.08% to $8.1 million in 2025, then sank by 178.53% to -$6.4 million in 2026.
• Business Quant data shows BEAM's Other Working Capital Changes at -$6.4 million in Q1 2026, $8.1 million in Q4 2025, and -$5.7 million in Q3 2025.